On March 13, the reporter of Beijing News learned from pharmacies, online platforms and other channels that the first batch of residents’ self-test covid-19 kits will be on sale soon. On March 11, the National Health Commission announced that the comprehensive group of joint prevention and control mechanism of the State Council for covid-19 virus pneumonia decided to add antigen detection as a supplement on the basis of nucleic acid detection.
According to the application plan for covid-19 virus antigen detection (for Trial Implementation) organized and formulated by the comprehensive group of the State Council for the joint prevention and control mechanism of covid-19 virus pneumonia epidemic, the applicable groups for antigen detection include three categories, namely, those who go to grass-roots medical and health institutions with respiratory tract, fever and other symptoms within 5 days; Isolation observation personnel, including personnel in home isolation observation, close connection and secondary close connection, entry isolation observation, sealing and control area; Community residents with antigen self-test needs. Community residents who need self-test can purchase antigen test reagents for self-test through retail pharmacies, online sales platforms and other channels. On March 12, the State Food and Drug Administration issued a notice approving the application change of covid-19 antigen product self-test application of five enterprises: Nanjing Nanjing Vazyme Biotech Co.Ltd(688105) , Beijing jinwofu, Shenzhen Huada Yinyuan, Guangzhou Guangzhou Wondfo Biotech Co.Ltd(300482) , Beijing huaketai biology.
Five covid-19 antigen self-test products have been officially approved, and several platforms are about to go on sale. On March 13, Yifeng pharmacy said that the first batch of covid-19 antigen self-test products sold to the public – new coronavirus (2019-ncov) antigen detection kit (colloidal gold method) is being transported. Residents can book through offline stores in the area covered by Yifeng pharmacy and official shopping malls, apps, meituan and other channels.
On March 13, the reporter of Beijing News logged into meituan, and its “buy medicine” channel has listed covid-19 virus antigen detection products. The price of one person / box is 32.8 yuan, and the price of 25 people / box is 498 yuan. It is expected to be delivered in 1-3 days. The page also shows that the commodity is a pre-sale commodity. There is a delay in delivery during the pre-sale period. It is expected to be delivered on the 20th. It is also reported that meituan pharmacy has also cooperated with several chain pharmacies such as Lbx Pharmacy Chain Joint Stock Company(603883) pharmacy, Guoda pharmacy, Gaoji medical, Haiwang Xingchen, Dashenlin Pharmaceutical Group Co.Ltd(603233) pharmacy and quanyuantang pharmacy. It is expected to launch covid-19 antigen self-test products synchronously with offline pharmacies within a week to jointly provide users with 30 minute door-to-door drug delivery service.
Another chain drugstore Lbx Pharmacy Chain Joint Stock Company(603883) announced on March 12 that it had reached cooperation with Guangzhou Guangzhou Wondfo Biotech Co.Ltd(300482) and the first batch of covid-19 antigen rapid test products had been on the way of logistics and transportation and was expected to be put on sale in stores in the near future. The first batch of products will be landed in the stores of Lbx Pharmacy Chain Joint Stock Company(603883) pharmacy in 12 provinces and cities including Shanghai, Hunan and Jiangsu.
Gaoji health, a new medical retail platform of Gaoji medical, also announced on March 12 that Gaoji medical is cooperating with Guangzhou Guangzhou Wondfo Biotech Co.Ltd(300482) , Nanjing Nanjing Vazyme Biotech Co.Ltd(688105) , Shenzhen Huada Yinyuan, Beijing jinwofu and other companies, and the first batch of covid-19 antigen rapid test products will be put on the shelves in Henan, Jiangxi and Liaoning markets, Gaoji Health Pro wechat applet will provide online ordering services for customers all over the country.
At the same time, more enterprises are also stepping up the research and development of antigen detection products. On March 11, Andon Health Co.Ltd(002432) Chairman Liu Yi said in an interview with the Beijing news that he would pay close attention to the progress and make preparations in advance from the aspects of raw materials, products, channels and so on. On March 11, Shenzhen national infectious disease clinical medicine research center and Shenzhen Third People’s Hospital signed a binding letter of intent with Hybio Pharmaceutical Co.Ltd(300199) to exclusively authorize Hybio Pharmaceutical Co.Ltd(300199) to carry out the commercial development, registration and sales of “domestic novel coronavirus antigen detection reagent”.
